You have 9 free searches left this month | for more free features.

lymphocytic leukemia

Showing 5401 - 5425 of 6,274

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Seoul (donor natural killer cell infusion)

Completed
  • Brain and Central Nervous System Tumors
  • +8 more
  • donor natural killer cell infusion
  • Seoul, Korea, Republic of
    University of Ulsan, Asan Medical Center
Feb 18, 2013

Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in Birmingham, London, Cardiff (cytarabine, daunorubicin HCl,

Completed
  • Leukemia
  • +2 more
  • Birmingham, England, United Kingdom
  • +2 more
Dec 17, 2013

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chicago (tipifarnib)

Completed
  • Chronic Myeloproliferative Disorders
  • +4 more
  • Chicago, Illinois
    University of Chicago Cancer Research Center
Feb 8, 2013

Leukemia, Lymphoma Trial in Columbus (romidepsin)

Completed
  • Leukemia
  • Lymphoma
  • Columbus, Ohio
    Arthur G. James Cancer Hospital - Ohio State University
Jan 30, 2013

Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in United States (PCI-24781)

Completed
  • Lymphoma
  • +2 more
  • San Francisco, California
  • +7 more
Feb 27, 2014

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Duarte, Los Angeles, Sacramento (decitabine)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • Duarte, California
  • +3 more
Feb 13, 2013

Hyperglycemia, Leukemia Trial in New Brunswick (insulin glargine recombinant, therapeutic insulin)

Withdrawn
  • Hyperglycemia
  • Leukemia
  • insulin glargine recombinant
  • therapeutic insulin
  • New Brunswick, New Jersey
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me
Aug 29, 2013

Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Houston (decitabine, romidepsin)

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • Houston, Texas
    M.D. Anderson Cancer Center at University of Texas
Feb 8, 2013

Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in Seoul (biological, drug, procedure)

Completed
  • Leukemia
  • +2 more
  • anti-thymocyte globulin
  • +7 more
  • Seoul, Korea, Republic of
    Asan Medical Center - University of Ulsan College of Medicine
Mar 25, 2013

Leukemia Trial in Switzerland (filgrastim, rituximab, CHOP regimen)

Completed
  • Leukemia
  • filgrastim
  • +7 more
  • Aarau, Switzerland
  • +10 more
May 14, 2012

Leukemia Trial in Houston (White Blood Cell Transfusion)

Completed
  • Leukemia
  • White Blood Cell Transfusion
  • Houston, Texas
    UT MD Anderson Cancer Center
Nov 1, 2013

Leukemia, MDS Trial in Houston (exatecan mesylate)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • exatecan mesylate
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
May 15, 2012

Acute Promyelocytic Leukemia Trial in Chicago (Tamibarotene, Arsenic trioxide)

Terminated
  • Acute Promyelocytic Leukemia
  • Chicago, Illinois
    Northwestern University
Oct 28, 2013

Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome, Ph^1^, Absent, B-cell Childhood Acute Lymphoblastic Leukemia

Unknown status
  • Childhood Acute Lymphoblastic Leukemia
  • +2 more
  • Tianjin, Tianjin, China
    Department of Pediatrics, Institute of Hematology and Blood Dise
Nov 20, 2013

Breast Cancer, Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Completed
  • Breast Cancer
  • +6 more
  • filgrastim
  • +4 more
  • Lexington, Kentucky
  • +3 more
Apr 25, 2013

Leukemia Trial in Rochester (filgrastim, cladribine, cytarabine)

Completed
  • Leukemia
  • filgrastim
  • +3 more
  • Rochester, New York
    James P. Wilmot Cancer Center at University of Rochester Medical
Oct 14, 2013

CHRONIC LYMPHOCYTIC B-LEUKEMIA Trial (IL-2 secreting and hCL4OL-expressing autologous B-CLL cells, IL-2, CD40L)

Withdrawn
  • CHRONIC LYMPHOCYTIC B-LEUKEMIA
  • IL-2 secreting and hCL4OL-expressing autologous B-CLL cells
  • +4 more
  • (no location specified)
May 18, 2012

Leukemia Trial in New Brunswick (choline magnesium trisalicylate, Dexamethasone)

Terminated
  • Leukemia
  • New Brunswick, New Jersey
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me
Nov 18, 2013

Acute Lymphoblastic Leukemia Trial in Atlanta (Sirolimus, PEG-asparaginase)

Withdrawn
  • Acute Lymphoblastic Leukemia
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Nov 30, 2013

Chronic Myeloproliferative Disorders, Fatigue, Leukemia Trial in New York (St. John's wort)

Completed
  • Chronic Myeloproliferative Disorders
  • +7 more
  • St. John's wort
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jan 17, 2013

GVHD, Leukemia Trial in Los Angeles (biological, drug, procedure, radiation)

Unknown status
  • Graft Versus Host Disease
  • Leukemia
  • anti-thymocyte globulin
  • +6 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Nov 5, 2013

Lymphoma, Solid Tumor Trial in New York (L-778,123, paclitaxel)

Completed
  • Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 20, 2013

Metastatic Melanoma Trial in San Francisco (Sutent (sunitinib))

Completed
  • Metastatic Melanoma
  • Sutent (sunitinib)
  • San Francisco, California
    California Pacific Medical Center
Feb 22, 2014

Chronic Myeloid Leukemia Complete Cytogenetic Response After

Completed
  • Chronic Myeloid Leukemia
  • HRQOL Survey Packet
  • Ancona, Italy
  • +24 more
Jan 21, 2014

Acute Myeloid Leukemia, MDS Trial in Singapore (CD8+ T-cell depleted donor lymphocyte infusion)

Unknown status
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • CD8+ T-cell depleted donor lymphocyte infusion
  • Singapore, Singapore
    Department of Hematology-Oncology, National University Hospital
Jan 7, 2014